Stilbenes in food and medicinal plants have been described as potent antiphlogistic and antioxidant compounds, and therefore, they present an interesting potential for the development of dietary supplements. Among them, macasiamenene F (MF) has recently been shown to be an effective anti-inflammatory and cytoprotective agent that dampens peripheral and CNS inflammation in vitro. Nevertheless, this promising molecule, like other stilbenes and a large percentage of drugs under development, faces poor water solubility, which results in trickier in vivo administration and low bioavailability. With the aim of improving MF solubility and developing a form optimized for in vivo administration, eight types of conventional liposomal nanocarriers and one type of PEGylated liposomes were formulated and characterized. In order to select the appropriate form of MF encapsulation, the safety of MF liposomal formulations was evaluated on THP-1 and THP-1-XBlue-MD2-CD14 monocytes, BV-2 microglia, and primary cortical neurons in culture. Furthermore, the cellular uptake of liposomes and the effect of encapsulation on MF anti-inflammatory effectiveness were evaluated on THP-1-XBlue-MD2-CD14 monocytes and BV-2 microglia. MF (5 mol %) encapsulated in PEGylated liposomes with an average size of 160 nm and polydispersity index of 0.122 was stable, safe, and the most promising form of MF encapsulation keeping its cytoprotective and anti-inflammatory properties.
- Publikační typ
- časopisecké články MeSH
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has prompted great interest in novel broad-spectrum antivirals, including perylene-related compounds. In the present study, we performed a structure-activity relationship analysis of a series of perylene derivatives, which comprised a large planar perylene residue, and structurally divergent polar groups connected to the perylene core by a rigid ethynyl or thiophene linker. Most of the tested compounds did not exhibit significant cytotoxicity towards multiple cell types susceptible to SARS-CoV-2 infection, and did not change the expressions of cellular stress-related genes under normal light conditions. These compounds showed nanomolar or sub-micromolar dose-dependent anti-SARS-CoV-2 activity, and also suppressed the in vitro replication of feline coronavirus (FCoV), also termed feline infectious peritonitis virus (FIPV). Perylene compounds exhibited high affinity for liposomal and cellular membranes, and efficiently intercalated into the envelopes of SARS-CoV-2 virions, thereby blocking the viral-cell fusion machinery. Furthermore, the studied compounds were demonstrated to be potent photosensitizers, generating reactive oxygen species (ROS), and their anti-SARS-CoV-2 activities were considerably enhanced after irradiation with blue light. Our results indicated that photosensitization is the major mechanism underlying the anti-SARS-CoV-2 activity of perylene derivatives, with these compounds completely losing their antiviral potency under red light. Overall, perylene-based compounds are broad-spectrum antivirals against multiple enveloped viruses, with antiviral action based on light-induced photochemical damage (ROS-mediated, likely singlet oxygen-mediated), causing impairment of viral membrane rheology.
- MeSH
- antivirové látky farmakologie chemie MeSH
- COVID-19 * MeSH
- kočky MeSH
- perylen * farmakologie MeSH
- reaktivní formy kyslíku MeSH
- SARS-CoV-2 MeSH
- singletový kyslík MeSH
- virion MeSH
- virový obal MeSH
- zvířata MeSH
- Check Tag
- kočky MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Bovine papillomavirus type 1 L1 protein was produced in a baculovirus expression system and purified as virus-like particles (VLPs) by affinity chromatography using lectins. The morphological integrity of VLPs was confirmed by electron microscopy. Differences between the two detected variants were deciphered by mass spectrometry of peptides (MALDI-TOF). Mice were immunized with purified VLPs in doses of 10, 25, or 50 μg in combination with 1% saponin and 15% alhydrogel per dose as adjuvants. Analysis of the humoral immune response revealed increased levels of specific antibodies detected 3 weeks after the first immunization in all groups of animals. This was further significantly increased by the booster applied 3 weeks after the first dose, with the best immune response in a group of mice immunized by the largest dose of antigen. BPV1 L1 VLPs purified by affinity chromatography using lectins could be used for prophylactic immunization in veterinary medicine.
- Publikační typ
- časopisecké články MeSH
The direct tailoring of the size, composition, or number of layers belongs to the advantages of 3D printing employment in producing orodispersible films (ODFs) compared to the frequently utilized solvent casting method. This study aimed to produce porous ODFs as a substrate for medicated ink deposited by a 2D printer. The innovative semi-solid extrusion 3D printing method was employed to produce multilayered ODFs, where the bottom layer assures the mechanical properties. In contrast, the top layer provides a porous structure for ink entrapment. Hydroxypropyl methylcellulose and polyvinyl alcohol were utilized as film-forming polymers, glycerol as a plasticizer, and sodium starch glycolate as a disintegrant in the bottom matrix. Several porogen agents (Aeroperl® 300, Fujisil®, Syloid® 244 FP, Syloid® XDP 3050, Neusilin® S2, Neusilin® US2, and Neusilin® UFL2) acted as porosity enhancers in the two types of top layer. ODFs with satisfactory disintegration time were prepared. The correlation between the porogen content and the mechanical properties was proved. A porous ODF structure was detected in most samples and linked to the porogen content. SSE 3D printing represents a promising preparation method for the production of porous ODFs as substrates for subsequent drug deposition by 2D printing, avoiding the difficulties arising in casting or printing medicated ODFs directly.
- Publikační typ
- časopisecké články MeSH
Východiska: Prognóza pacientů s karcinomem kolorekta (colorectal cancer – CRC) závisí především na rozsahu onemocnění v době diagnózy, proto je brzký záchyt jedním z hlavních předpokladů úspěšné léčby. Současný výzkum ukazuje, že exozomální dlouhé nekódující RNA (lncRNA) jsou spojeny s rozvojem nádorových onemocnění. Jelikož jsou lncRNA často tkáňově specifické, jejich kvantifikace v exozomech se nabízí jako neinvazivní metoda pro včasnou detekci CRC. V naší práci jsme se zaměřili na optimalizaci protokolu pro analýzu exozomálních lncRNA z krevního séra pacientů s CRC jako potenciálních diagnostických biomarkerů. Materiál a metody: Exozomy byly izolovány pomocí gelové chromatografie ze 150 μl séra pacientů s CRC a zdravých dárců. Jejich kvalita a kvantita byla potvrzena elektronovou mikroskopií a analýzou dynamického rozptylu světla (dynamic light scattering – DLS) a proteinové markery byly detekovány metodou Western blot. Po izolaci RNA byly ze vzorků připraveny cDNA knihovny, které byly sekvenovány pomocí NextSeq 550. Výsledky: Úspěšně jsme izolovali exozomy a ověřili jsme jejich vlastnosti několika různými metodami. Knihovny byly připraveny ze všech vzorků i přes velmi nízký objem výchozího materiálu. Sekvenační data potvrzují přítomnost protein kódující (50 %) i nekódující RNA, kterou tvoří především lncRNA (28,2 %), pseudogeny (15,2 %) a další typy RNA (6,5 %). Výsledky dále ukázaly významně změněné hladiny některých lncRNA, na základě jejichž exprese bylo možné odlišit vzorky od pacientů s CRC od vzorků zdravých kontrol. Pomocí analýzy obohacení genové sady (gene set enrichment analysis – GSEA) jsme pozorovali významně obohacené třídy genů, které souvisejí s opravami DNA nebo regulací buněčného cyklu. Závěr: Naše pilotní data naznačují, že lncRNA představují významnou část RNA přítomné v exozomech a jejich rozdílné hladiny mají schopnost odlišit CRC pacienty od zdravých kontrol. Analýza obohacených genů zároveň prokázala významné zastoupení lncRNA podílejících se na regulaci buněčného cyklu a oprav DNA, což naznačuje jejich možné zapojení do procesů kancerogeneze. Výsledky je však třeba ověřit na větším souboru pacientů.
Background: The prognosis of patients with colorectal cancer (CRC) depends mainly on the extent of the disease at the time of diagnosis; therefore, early detection is one of the main prerequisites for successful treatment. Current research shows that exosomal long non-coding RNAs (lncRNAs) are associated with cancer development. As lncRNAs are often tissue specific, their quantification in exosomes is proposed as a non-invasive method for early detection of CRC. In this study, we aimed to optimize a protocol for analyzing exosomal lncRNAs from blood serum of CRC patients as potential diagnostic biomarkers. Material and methods: Exosomes were isolated by gel chromatography from 150 μl of serum of CRC patients and healthy donors. Their quality and quantity were confirmed by electron microscopy and dynamic light scattering (DLS) analysis; protein markers were detected by Western blot. After RNA isolation, cDNA libraries were prepared and sequenced using NextSeq 550. Results: We successfully isolated exosomes and verified them by several methods. Libraries were prepared from all samples despite very low volume of starting material. The sequencing data confirmed the presence of both protein-coding (50%) and non-coding RNAs, which consisted mainly of lncRNAs (28.2%), pseudogenes (15.2%) and other RNA types (6.5%). The results also showed significantly altered levels of some lncRNAs that could distinguish samples from CRC patients and healthy controls. Using gene set enrichment analysis (GSEA), we observed significantly enriched classes of genes related to DNA repair or cell cycle regulation. Conclusion: Our preliminary data suggest that lncRNAs represent a significant fraction of the RNA present in exosomes and that their distinct levels can separate CRC patients from healthy controls. The analysis of enriched genes also showed a significant representation of lncRNAs involved in cell cycle regulation and DNA repair, suggesting their possible involvement in cancerogenesis. However, the results need to be verified in a larger cohort of patients.
The growing need for processing natural lipophilic and often volatile substances such as thymol, a promising candidate for topical treatment of intestinal mucosa, led us to the utilization of solid-state nuclear magnetic resonance (ss-NMR) spectroscopy for the rational design of enteric pellets with a thymol self-emulsifying system (SES). The SES (triacylglycerol, Labrasol®, and propylene glycol) provided a stable o/w emulsion with particle size between 1 and 7 μm. The ex vivo experiment confirmed the SES mucosal permeation and thymol delivery to enterocytes. Pellets W90 (MCC, Neusilin®US2, chitosan) were prepared using distilled water (90 g) by the M1-M3 extrusion/spheronisation methods varying in steps number and/or cumulative time. The pellets (705-740 μm) showed mostly comparable properties-zero friability, low intraparticular porosity (0-0.71%), and relatively high density (1.43-1.45%). They exhibited similar thymol release for 6 h (burst effect in 15th min ca. 60%), but its content increased (30-39.6 mg/g) with a shorter process time. The M3-W90 fluid-bed coated pellets (Eudragit®L) prevented undesirable thymol release in stomach conditions (<10% for 3 h). A detailed, ss-NMR investigation revealed structural differences across samples prepared by M1-M3 methods concerning system stability and internal interactions. The suggested formulation and methodology are promising for other lipophilic volatiles in treating intestinal diseases.
- Publikační typ
- časopisecké články MeSH
- Publikační typ
- tisková chyba MeSH
- Publikační typ
- abstrakt z konference MeSH
Modern pharmaceutical technology still seeks new excipients and investigates the further use in already known ones. An example is magnesium aluminometasilicate Neusilin® US2 (NEU), a commonly used inert filler with unique properties that are usable in various pharmaceutical fields of interest. We aimed to explore its application in hypromellose matrix systems (HPMC content 10-30%) compared to the traditionally used microcrystalline cellulose (MCC) PH 102. The properties of powder mixtures and directly compressed tablets containing individual fillers NEU or MCC, or their blend with ratios of 1.5:1, 1:1, and 0.5:1 were investigated. Besides the routine pharmaceutical testing, we have enriched the matrices' evaluation with a biorelevant dynamic dissolution study and advanced statistical analysis. Under the USP apparatus 2 dissolution test, NEU, individually, did not provide advantages compared to MCC. The primary limitations were the burst effect increase followed by faster drug release at the 10-20% HPMC concentrations. However, the biorelevant dynamic dissolution study did not confirm these findings and showed similarities in dissolution profiles. It indicates the limitations of pharmacopoeial methods in matrix tablet development. Surprisingly, the NEU/MCC blend matrices at the same HPMC concentration showed technologically advantageous properties. Besides improved flowability, tablet hardness, and a positive impact on the in vitro drug dissolution profile toward zero-order kinetics, the USP 2 dissolution data of the samples N75M50 and N50M50 showed a similarity to those obtained from the dynamic biorelevant apparatus with multi-compartment structure. This finding demonstrates the more predictable in vivo behaviour of the developed matrix systems in human organisms.
- Publikační typ
- časopisecké články MeSH
Mikročástice jsou široce používány v nesčetných oblastech průmyslu, jako jsou farmaceutika, potraviny, kosmetika a další. Ve srovnání s tradičními metodami pro syntézu mikročástic poskytují mikrofluidní techniky výkonné platformy pro vytváření vysoce kontrolovatelných kapek emulze jako šablon pro výrobu uniformních mikročástic s pokročilými strukturami a funkcemi. Mikrofluidní techniky mohou generovat kapky emulze s přesně řízenou velikostí, tvarem a složením. Přesnější proces přípravy je účinným nástroj ke kontrole profilu uvolňování léčiva a přináší také snadno dostupnou reprodukovatelnost. Článek poskytuje informace o základních nastaveních droplet-based techniky a příklady typů mikročástic připravitelných touto metodou.
Microparticles are widely used in myriad fields such as pharmaceuticals, foods, cosmetics, and other industrial fields. Compared with traditional methods for synthesizing microparticles, microfluidic techniques provide very powerful platforms for creating highly controllable emulsion droplets as templates for fabricating uniform microparticles with advanced structures and functions. Microfluidic techniques can generate emulsion droplets with precisely controlled size, shape, and composition. A more precise preparation process brings an effective tool to control the release profile of the drug and introduces an easily accessible reproducibility. The paper gives information about basic droplet-based set-ups and examples of attainable microparticle types preparable by this method.
- Klíčová slova
- metoda odpaření rozpouštědla, mikrokanálky,
- MeSH
- mikrofluidika metody MeSH
- nanočástice * MeSH
- Publikační typ
- práce podpořená grantem MeSH